Genevant Sciences
Tracy Meffen has served as Vice President, Quality & Regulatory Affairs of Genevant Sciences Corporation since July 2019. Previously, she was Head of Quality & Regulatory Affairs from Genevant’s inception in April 2018. Prior to joining Genevant, Tracy served in QA and RA management roles with Arbutus Biopharma, Lungpacer Medical, and at McKesson. She brings over 25 years of experience in drug and medical device development at various organizations including INEX, Eli Lilly and Genzyme. Tracy holds a MS in Regulatory Affairs from Northeastern University and a BSc in Chemistry from the University of Hull as well as RAC credentials for the United States, Europe and Canada.
This person is not in any offices
Genevant Sciences
Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. They leverage world-class delivery systems and related technologies to bring new medicines to patients who need them. Genevant does this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows them to maintain our leadership position in the space.